People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Terpenoid Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $2.3M | $25.3M | 2016 |
David J. Wiemer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David J. Wiemer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert W. Karr | 1 | 4 |
| Mark J Drish | 1 | 2 |
| David F. Wiemer | 1 | 1 |
| Jeffrey D. Neighbors | 1 | 1 |
| Curt J. Nelson | 1 | 1 |
| David F Weimer | 1 | 1 |
| Steven D. Collins | 1 | 1 |
| Raymond J. Hohl | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.